Table 1 Relationships between SNCG expression and clinicopathological characteristics in cervical cancer patients
From: Silencing of Synuclein-γ inhibits human cervical cancer through the AKT signaling pathway
| Characteristics | SNCG expression (30) | P | |
|---|---|---|---|
| Low (n) | High (n) | ||
| Age | |||
| < 50 | 6 | 7 | 0.532 |
| ≥ 50 | 6 | 11 | |
| Tumor size (cm) | |||
| ≤ 4 | 10 | 9 | 0.021* |
| > 4 | 3 | 8 | |
| FIGO staging | |||
| I-II | 9 | 8 | 0.016* |
| III–IV | 3 | 10 | |
| Histological grade | |||
| Well differentiated | 5 | 6 | 0.577 |
| Moderately to Poorly differentiated | 7 | 12 | |
| Pelvic lymph node metastasis | |||
| No | 11 | 10 | 0.021* |
| Yes | 2 | 7 | |